Cartiva
Medical Devices, 6120 Windward Pkwy, Alpharetta, Georgia, 30005, United States, 11-50 Employees
Phone Number: +16*********
Who is CARTIVA
Cartiva, Inc. is an evidence-based medical device company with the first and only FDA approved synthetic cartilage implant for the treatment of osteoarthritis. Cartivas synthetic cartilag...
Read More
-
Headquarters: 6120 Windward Pkwy, Alpharetta, Georgia, 30005, United States
-
Date Founded: 2011
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 0742
|
NAICS Code: 423450 |
Show More
Cartiva Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Cartiva
Answer: Cartiva's headquarters are located at 6120 Windward Pkwy, Alpharetta, Georgia, 30005, United States
Answer: Cartiva's phone number is +16*********
Answer: Cartiva's official website is https://cartiva.net
Answer: Cartiva's revenue is $10 Million to $25 Million
Answer: Cartiva's SIC: 0742
Answer: Cartiva's NAICS: 423450
Answer: Cartiva has 11-50 employees
Answer: Cartiva is in Medical Devices
Answer: Cartiva contact info: Phone number: +16********* Website: https://cartiva.net
Answer: Cartiva, Inc. is an evidence-based medical device company with the first and only FDA approved synthetic cartilage implant for the treatment of osteoarthritis. Cartivas synthetic cartilage is made of a biomedical polymer that mimics natural cartilage. The durable material is proven to withstand the repetitive compressive loads that occur clinically in the great toe joint, while the low coefficient of friction aids in smooth joint articulation and mobility. Cartivas implant offers patients a joint preserving alternative to fusion of the great toe with substantial pain reduction and improved range of motion and is backed by the largest and most rigorous clinical study for this condition. Cartiva is currently investigating use of its platform technology for additional indications, including near-term use in lesser metatarsal and CMC arthritis, and longer-term applications for the ankle, elbow and shoulder. Cartivas management team, board of directors and medical advisers are comprised of industry-recognized professionals who possess broad knowledge in orthopedics and extensive experience managing innovative medical devices from development through clinical trials, FDA approval and successful commercialization. Cartivas venture investors include New Enterprise Associates, Windham Venture Partners and Domain Associates.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month